MedTrace Logo

Voiceitt for People With Impairments in Speech

NCT06874322 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-08-08

No results posted yet for this study

Summary

The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.

Conditions

  • Speech Impairment
  • Speech Disorder

Interventions

OTHER

Voiceitt

Participants will use Voiceitt App

Sponsors & Collaborators

  • Duquesne University

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Brad E Dicianno, MD · University of Pittsburgh

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-25
Primary Completion
2026-06-30
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06874322 on ClinicalTrials.gov